α1-Antitrypsin deficiency
Open Access
- 21 February 2024
- journal article
- research article
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (2) , 225-229
Abstract
α1-Antitrypsin deficiency is classified as an orphan disease. The main target organs are the lungs, liver and skin. Typical respiratory manifestations are emphysema and bronchiectasis, which often lead to disability as the disease progresses. To slow the progression of lung pathology, replacement therapy with an α1-proteinase inhibitor is used worldwide.The aim of this article is to familiarize physicians with a rare lung disease that leads to the early development of emphysema and chronic obstructive pulmonary disease.Conclusion. Early detection of lung pathology associated with α1-antitrypsin deficiency allows timely prescription of the necessary replacement therapy, which in turn leads to an increase in the duration and improvement in the quality of life of patients with this pathology.Keywords
This publication has 18 references indexed in Scilit:
- Alpha-1 antitrypsin deficiency–associated panniculitisJournal of the American Academy of Dermatology, 2022
- European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiencyEuropean Respiratory Journal, 2017
- Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)The Lancet Respiratory Medicine, 2017
- 1-Antitrypsin deficiency {middle dot} 5: Intravenous augmentation therapy: current understandingThorax, 2004
- American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin DeficiencyAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosisJournal of Clinical Investigation, 1999
- Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)European Respiratory Journal, 1999
- α1-Antitrypsin: A Guardian of Vascular TissueMayo Clinic Proceedings, 1994
- Arterial Fibromuscular Dysplasia Associated With Severe α1-Antitrypsin DeficiencyMayo Clinic Proceedings, 1994
- Alpha1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British thoracic associationClinical Radiology, 1982